OFVIX
Price
$20.22
Change
+$0.23 (+1.15%)
Updated
Jun 6 closing price
Net Assets
233.33M
RMEBX
Price
$57.95
Change
+$0.31 (+0.54%)
Updated
Jun 6 closing price
Net Assets
105.22B
Interact to see
Advertisement

OFVIX vs RMEBX

Header iconOFVIX vs RMEBX Comparison
Open Charts OFVIX vs RMEBXBanner chart's image
O'Shaughnessy Market Leaders Value I
Price$20.22
Change+$0.23 (+1.15%)
VolumeN/A
Net Assets233.33M
American Funds American Mutual R2E
Price$57.95
Change+$0.31 (+0.54%)
VolumeN/A
Net Assets105.22B
OFVIX vs RMEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
OFVIX vs. RMEBX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OFVIX is a Buy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 105B vs. OFVIX (233M). OFVIX pays higher dividends than RMEBX: OFVIX (1.94) vs RMEBX (1.16). OFVIX was incepted earlier than RMEBX: OFVIX (9 years) vs RMEBX (11 years). RMEBX (1.07) is less costly to investors than OFVIX (0.54). OFVIX is a more actively managed with annual turnover of: 53.57 vs. RMEBX (31.00). RMEBX has a lower initial minimum investment than OFVIX: RMEBX (250) vs OFVIX (10000). RMEBX annual gain was more profitable for investors over the last year : 8.87 vs. OFVIX (4.71). OFVIX return over 5 years is better than : 73.49 vs. RMEBX (50.55).
OFVIXRMEBXOFVIX / RMEBX
Total Expense Ratio0.541.0750%
Annual Report Gross Expense Ratio0.541.0750%
Fund Existence9 years11 years-
Gain YTD2.9885.84251%
Front LoadN/AN/A-
Min. Initial Investment100002504,000%
Min. Initial Investment IRAN/AN/A-
Net Assets233M105B0%
Annual Yield % from dividends1.941.16168%
Returns for 1 year4.718.8753%
Returns for 3 years16.9717.3298%
Returns for 5 years73.4950.55145%
Returns for 10 yearsN/A68.95-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GLUE5.010.39
+8.44%
Monte Rosa Therapeutics
PHR26.811.03
+4.00%
Phreesia
USAU14.110.44
+3.22%
US Gold Corp
IDXX524.912.70
+0.52%
IDEXX Laboratories
UGI35.510.17
+0.48%
UGI Corp